Amsterdam, Netherlands

Janneke M Verhagen

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Janneke M Verhagen: Innovator in Vaccine Development

Introduction

Janneke M Verhagen is a prominent inventor based in Amsterdam, Netherlands. She has made significant contributions to the field of vaccine development, particularly in the fight against respiratory syncytial virus (RSV). With a total of three patents to her name, her work is paving the way for innovative solutions in healthcare.

Latest Patents

One of her latest patents focuses on a vaccine against RSV. The invention relates to novel nucleic acid molecules encoding a pre-fusion RSV F protein or an immunologically active part thereof. The pre-fusion RSV F protein comprises the amino acid sequence of SEQ ID NO: 1 or 2. This invention further explores the use of these nucleic acid molecules, or vectors containing them, as a vaccine against respiratory syncytial virus (RSV).

Career Highlights

Janneke M Verhagen is associated with Janssen Vaccines & Prevention B.V., where she continues to advance her research and development efforts. Her work is instrumental in creating effective vaccines that can combat viral infections.

Collaborations

One of her notable collaborators is Johannes Petrus Maria Langedijk, who works alongside her in the pursuit of innovative vaccine solutions.

Conclusion

Janneke M Verhagen's contributions to vaccine development, particularly against RSV, highlight her role as a key innovator in the field. Her ongoing research and patents are essential for advancing public health initiatives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…